The global diabetic neuropathy market—focused on managing nerve damage caused by diabetes—is expected to grow from approximately USD 4.34 billion in 2023 to USD 7.28 billion by 2030, registering ...
According to recent insights by DataM Intelligence, the blood cancer drugs market is projected to reach USD 75.4 billion by 2032, up from an estimated USD 38.9 billion in 2024. This surge is fuel...